Leland Gershell - Net Worth and Insider Trading

Leland Gershell Net Worth

The estimated net worth of Leland Gershell is at least $1,446 dollars as of 2024-03-28. Leland Gershell is the CHIEF FINANCIAL OFFICER of Capricor Therapeutics Inc and owns about 210 shares of Capricor Therapeutics Inc (CAPR) stock worth over $1,446. Leland Gershell is also the CFO of Tonix Pharmaceuticals Holding Corp and owns about 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) stock worth over $0. Details can be seen in Leland Gershell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Leland Gershell has not made any transactions after 2016-03-16 and currently still holds the listed stock(s).

Transaction Summary of Leland Gershell

To

Leland Gershell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Leland Gershell owns 2 companies in total, including Capricor Therapeutics Inc () , and Tonix Pharmaceuticals Holding Corp () .

Click here to see the complete history of Leland Gershell’s form 4 insider trades.

Insider Ownership Summary of Leland Gershell

Ticker Comapny Transaction Date Type of Owner
Capricor Therapeutics Inc 2016-03-16 Chief Financial Officer
Tonix Pharmaceuticals Holding Corp 2015-09-28 Chief Financial Officer

Leland Gershell Latest Holdings Summary

Leland Gershell currently owns a total of 2 stocks. Among these stocks, Leland Gershell owns 210 shares of Capricor Therapeutics Inc (CAPR) as of March 16, 2016, with a value of $1,446 and a weighting of 100%. Leland Gershell also owns 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) as of September 28, 2015, with a value of $0 and a weighting of 0%.

Latest Holdings of Leland Gershell

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CAPR Capricor Therapeutics Inc 2016-03-16 210 6.89 1,446
TNXP Tonix Pharmaceuticals Holding Corp 2015-09-28 0 0.27 0

Holding Weightings of Leland Gershell


Leland Gershell Form 4 Trading Tracker

According to the SEC Form 4 filings, Leland Gershell has made a total of 0 transactions in Capricor Therapeutics Inc (CAPR) over the past 5 years. The most-recent trade in Capricor Therapeutics Inc is the acquisition of 210 shares on March 16, 2016, which cost Leland Gershell around $5,040.

According to the SEC Form 4 filings, Leland Gershell has made a total of 0 transactions in Tonix Pharmaceuticals Holding Corp (TNXP) over the past 5 years. The most-recent trade in Tonix Pharmaceuticals Holding Corp is the acquisition of 0 shares on September 28, 2015, which cost Leland Gershell around $2,332.

Insider Trading History of Leland Gershell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Leland Gershell Trading Performance

GuruFocus tracks the stock performance after each of Leland Gershell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Leland Gershell is 64.5%. GuruFocus also compares Leland Gershell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Leland Gershell within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Leland Gershell's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Leland Gershell

Average Relative Return

46.26%

Average relative return per transaction

Outperforming Transactions

50%

2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 8.85 64.5 58.26 46.26 -30.14 -54.55
Relative Return to S&P 500(%) 5.18 60.38 54.36 32.32 -41.95 -66.25

Leland Gershell Ownership Network

Ownership Network List of Leland Gershell

No Data

Ownership Network Relation of Leland Gershell


Leland Gershell Owned Company Details

What does Capricor Therapeutics Inc do?

Who are the key executives at Capricor Therapeutics Inc?

Leland Gershell is the Chief Financial Officer of Capricor Therapeutics Inc. Other key executives at Capricor Therapeutics Inc include CHIEF BUSINESS OFFICER Xavier Avat , director & CHIEF EXECUTIVE OFFICER Linda Marban , and EVP & GENERAL COUNSEL Karen Krasney .

Capricor Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Leland Gershell made no insider transaction in Capricor Therapeutics Inc (). Other recent insider transactions involving Capricor Therapeutics Inc () include a net purchase of 7,993 shares made by David B Musket , a net sale of 17,772 shares made by Xavier Avat , and a net purchase of 10,000 shares made by Collier Earl M Jr .

In summary, during the past 3 months, insiders sold 0 shares of Capricor Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,772 shares of Capricor Therapeutics Inc () were sold and 22,993 shares were bought by its insiders, resulting in a net purchase of 5,221 shares.

Capricor Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Capricor Therapeutics Inc Insider Transactions

No Available Data

Leland Gershell Mailing Address

Above is the net worth, insider trading, and ownership report for Leland Gershell. You might contact Leland Gershell via mailing address: C/o Tonix Pharmaceuticals Holding Corp, 509 Madison Ave., Ste 306, New York Ny 10022.

Discussions on Leland Gershell

No discussions yet.